期刊文献+

血清miRNA作为胃癌早期诊断标记物的初步研究 被引量:13

Study on Serum miRNAs as Biomarkers for Early Diagnosis of Gastric Cancer
下载PDF
导出
摘要 背景:已有研究发现部分血清miRNA与胃癌密切相关,但对早期胃癌的研究较少见。目的:探讨血清miR-1、miR-20a、miR-27a、miR-34a、miR-423-5p表达在胃癌尤其是早期胃癌诊断中的价值。方法:采用qRT-PCR法检测180例胃癌患者(包括149例进展期胃癌和31例早期胃癌)、49例癌前变化患者、57名健康对照者的血清miR-1、miR-20a、miR-27a、miR-34a、miR-423-5p表达。采用ROC曲线判断miRNA的诊断敏感性和特异性。结果:胃癌患者血清miR-1、miR-20a、miR-34a、miR-423-5p表达显著升高(P<0.05),ROC曲线下面积(AUC)分别为0.894 9、0.814 8、0.644 8、0.589 7,四者联合的AUC为0.921 1,敏感性和特异性分别为85.8%和83.3%。早期胃癌中miR-1和miR-20a的表达明显升高(P<0.05),AUC分别为0.813 8和0.774 2,两者联合的AUC为0.865 3,敏感性和特异性分别为80.5%和83.6%。进展期胃癌中miR-1的表达显著高于早期胃癌(P=0.012 1),且术后表达明显降低(P=0.018 5)。结论:miR-1、miR-20a、miR-34a、miR-423-5p可作为肿瘤标记物对胃癌进行诊断,miR-1、miR-20a可作为诊断早期胃癌的标记物。 Background: Recently studies showed that some serum miRNAs are closely related to gastric cancer ( GC ) , but studies on early GC are rare. Aims: To investigate the values of serum miRNAs (miR-1, miR-20a, miR-27a, miR-34a, miR-423-Sp) for diagnosis of GC, especially early GC. Methods: qRT-PCR was used to detect expressions of serum miRNAs (miR-1, miR-20a, miR-27a, miR-34a, miR-423-5p) in 180 patients with GC (including 149 advanced GC and 31 early GC), 49 patients with precancerous change and 57 controls. ROC curve was used to evaluate the sensitivity and specificity of miRNAs. Results: Expressions of serum miR-1, miR-20a, miR-34a and miR-423-5p in GC patients were significantly increased (P 〈 0. 05) ; area under ROC curve (AUC) was 0. 894 9, 0. 814 8, 0. 644 8, 0. 589 7, respectively. AUC of these 4 combined miRNAs was 0. 921 1 ; sensitivity and specificity of combined miRNAs were 85.8% and 83.3% , respectively. Expressions of miR-I and miR-20a in early GC were significantly increased (P 〈0.05) , AUC were 0. 813 8 and 0. 774 2, respectively. AUC of combined miRNAs was 0. 865 3 ; sensitivity and specificity of combined miRNAs were 80.5% and 83.6% , respectively. Serum level of miR-1 was significantly higher in advanced GC patients than in early GC patients (P = 0. 012 1 ), and was significantly decreased after surgery (P = 0. 018 5 ). Conclusions: miR-1, miR-20a, miR-34a and miR-423-Sp may be used as potential biomarkers for the diagnosis of GC, especially miR- 1 and miR-20a which could be used for diagnosis of early GC.
出处 《胃肠病学》 2014年第4期198-202,共5页 Chinese Journal of Gastroenterology
关键词 微RNAS 胃肿瘤 早期诊断 ROC曲线 MicroRNAs Stomach Neoplasms Early Diagnosis ROC Curve
  • 相关文献

参考文献1

二级参考文献20

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献982

同被引文献111

引证文献13

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部